US Patent Issued to GLAXOSMITHKLINE BIOLOGICALS on Sept. 16 for "Modified meningococcal fHbp polypeptides" (Italian Inventors)

ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,415,838, issued on Sept. 16, was assigned to GLAXOSMITHKLINE BIOLOGICALS SA (Rixensart, Belgium).

"Modified meningococcal fHbp polypeptides" was invented by Matthew Bottomley (Siena, Italy), Enrico Malito (Siena, Italy), Manuele Martinelli (Siena, Italy) and Maria Scarselli (Siena, Italy).

According to the abstract* released by the U.S. Patent & Trademark Office: "Modified meningococcal fHbp polypeptides with increased stability."

The patent was filed on Feb. 13, 2024, under Application No. 18/440,212.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool....